at MarketWatch.com (May 15, 2013)
It's been a wild ride today for pharmaceutical developer Vermillion (VRML), jumping +19% at the...
It's been a wild ride today for pharmaceutical developer Vermillion (VRML), jumping +19% at the open on positive preliminary results for its PAD drug Vasclir, only to reverse course and tumble -13% as the biotech sector continues to collapse. Other biotech shares getting hit today: Cerus (CERS -5.2%), EXACT Sciences (EXAS -5.2%), Quest Diagnostics (DGX -5.2%), Gen-Probe (GPRO -3.8%), and (CPHD -2.6%).
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at MarketWatch.com (Mar 6, 2012)
at MarketWatch.com (Sep 29, 2011)
at MarketWatch.com (Sep 14, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs